Effect of bleomycin on DNA, RNA, protein, chromatin and on cell transformation by oncogenic RNA viruses
- PMID: 63969
Effect of bleomycin on DNA, RNA, protein, chromatin and on cell transformation by oncogenic RNA viruses
Abstract
Bleomycin (BLM) exclusively affects thymidine-containing compounds such as DNA and polydeoxyribonucleotides by releasing free thymine and leaving aldehyde functions. Molecular morphology and base sequence of the DNA strongly influence BLM activity. High BLM concentrations, besides modifying DNA into oligothyminic or athyminic nucleic acids, cause strand scissions. Enzymatic DNA and RNA synthesis is strongly influenced by BLM. The inhibition in DNA-dependent DNA polymerase and DNA-dependent RNA polymerase assays is of the non-competitive type. Protein biosynthesis in in vitro systems is not affected by BLM even at high concentrations. BLM turns out to be a strong inhibitor of DNase I and of DNase II; the inhibition is of the competitive type. The enzymatic activities of nucleases using RNA as substrate (RNase A, RNase B, Rnase T1, venom phosphodiesterase I and spleen phosphodiesterase II) are not influenced by this antibiotic. The antibiotic reduces cell proliferation (L5178y mouse lymphoma cells) in vitro in low concentrations by cytostasis and at higher concentrations by cytotoxicity. In BLM-treated L5178y cells, DNA synthesis is strongly reduced, while RNA and protein synthesis are not affected. In vivo, using growing quail oviducts, cell proliferation and cytodifferentiation are markedly inhibited after BLM treatment. This is attributed to the observed inhibition of DNA synthesis. RNA and protein synthesis as well as gene expression are not influenced by BLM under the conditions used. The selective inhibition of DNA synthesis in vivo may be caused by the following mechanisms: (1) competition of BLM with RNA; (2) blocking of the accessibility of DNA in chromatin to BLM, and (3) dependence from the repair processes. BLM inhibits growth of sarcomas, induced by oncogenic RNA viruses in vivo; well-developed tumours show regression after BLM treatment. Transformation of chick embryo fibroblasts by oncogenic RNA viruses in vitro and growth of these viruses is blocked by BLM; the most sensitive period for BLM inhibition is the time during the first period (integration of viral genome into cellular genome?) after infection.
Similar articles
-
Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro.Cancer Res. 1975 Aug;35(8):2160-8. Cancer Res. 1975. PMID: 1149031
-
Additive effects of bleomycin and neocarzinostatin on degradation of DNA, inhibition of DNA polymerase beta, and cell growth.Cancer Res. 1979 Sep;39(9):3768-73. Cancer Res. 1979. PMID: 89904
-
Bleomycin: action on growth of oncogenic RNA viruses and on cell transformation.Arch Virol. 1975;48(2):169-79. doi: 10.1007/BF01318149. Arch Virol. 1975. PMID: 50058
-
Actions of bleomycin on DNA ligase and polymerases.Prog Biochem Pharmacol. 1976;11:48-58. Prog Biochem Pharmacol. 1976. PMID: 63970 Review.
-
Relation between carcinogenesis, chromatin structure and poly(ADP-ribosylation) (review).Anticancer Res. 1991 Mar-Apr;11(2):489-527. Anticancer Res. 1991. PMID: 1905900 Review.
Cited by
-
A fast and reliable method for monitoring genomic instability in the model organism Caenorhabditis elegans.Arch Toxicol. 2021 Oct;95(10):3417-3424. doi: 10.1007/s00204-021-03144-7. Epub 2021 Aug 30. Arch Toxicol. 2021. PMID: 34458933 Free PMC article.